The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 19, 2023

Filed:

May. 31, 2022
Applicant:

Inscripta, Inc., Boulder, CO (US);

Inventors:

Burak Dura, Boulder, CO (US);

Phillip Belgrader, Pleasanton, CA (US);

Christian Siltanen, Boulder, CO (US);

William Watterson, Boulder, CO (US);

Bruce Chabansky, Boulder, CO (US);

David Stumbo, Boulder, CO (US);

Eric Smith, Boulder, CO (US);

Jorge Bernate, Boulder, CO (US);

Assignee:

INSCRIPTA, INC., Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/63 (2006.01); C12N 5/00 (2006.01); C12N 15/79 (2006.01); C07H 21/04 (2006.01); C12N 15/10 (2006.01); C12M 1/34 (2006.01); C12M 1/26 (2006.01); C12N 15/113 (2010.01); C12N 15/86 (2006.01); C12M 3/00 (2006.01); C12M 3/04 (2006.01); C12M 1/00 (2006.01); C12N 5/074 (2010.01); C12N 15/11 (2006.01); C12N 15/88 (2006.01); C12N 15/90 (2006.01); B01L 3/00 (2006.01); B01L 7/00 (2006.01); C12M 1/32 (2006.01); C12M 3/06 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1082 (2013.01); B01L 3/502761 (2013.01); B01L 7/00 (2013.01); C12M 23/12 (2013.01); C12M 23/16 (2013.01); C12M 23/42 (2013.01); C12M 23/50 (2013.01); C12M 27/10 (2013.01); C12M 29/04 (2013.01); C12M 33/14 (2013.01); C12M 41/36 (2013.01); C12M 43/00 (2013.01); C12M 47/02 (2013.01); C12M 47/04 (2013.01); C12N 5/0696 (2013.01); C12N 15/1065 (2013.01); C12N 15/1068 (2013.01); C12N 15/11 (2013.01); C12N 15/113 (2013.01); C12N 15/86 (2013.01); C12N 15/88 (2013.01); C12N 15/907 (2013.01); B01L 2200/0647 (2013.01); B01L 2300/0681 (2013.01); B01L 2300/123 (2013.01); B01L 2300/161 (2013.01); B01L 2400/0415 (2013.01); B01L 2400/0421 (2013.01); B01L 2400/0424 (2013.01); C12N 9/22 (2013.01); C12N 2310/20 (2017.05); C12N 2510/00 (2013.01); C12N 2740/10011 (2013.01); C12N 2740/15011 (2013.01); C12N 2750/14111 (2013.01); C12N 2800/80 (2013.01);
Abstract

Nucleic acid-guided nuclease editing in mammalian cells may include passaging mammalian cells, in an automated closed cell editing instrument, into smaller aggregates when the aggregates exceed 50-300 microns in size. A library of viral particles may be delivered to the mammalian cells at a multiplicity of infection such that each mammalian cell receives one or no viral particle. The library may include viral vectors with an editing cassette including a pair of gRNA coding sequence and donor DNA. Conditions may be provided to allow a viral vector of the viral vectors to integrate into the mammalian cells. Enriching for mammalian cells may be done with an integrated viral vector. A nucleic acid-guided nuclease or nuclease fusion or a coding sequence for a nucleic acid-guided nuclease or nuclease fusion may be delivered to the enriched mammalian cells and conditions may be provided to allow editing in the mammalian cells.


Find Patent Forward Citations

Loading…